Patents Assigned to Eli Lillly and Company
  • Glucagon-like peptide-1 analogs
    Patent number: 5981488
    Abstract: The invention provides extended-action GLP-1 based peptides and compositions that are useful for treating diabetes and minimize the risk of hypoglycemia.
    Type: Grant
    Filed: March 25, 1998
    Date of Patent: November 9, 1999
    Assignee: Eli Lillly and Company
    Inventor: James Arthur Hoffmann